0 true false false false false false false false false false true false false false true true true No description of principal activity 2023-05-01 Sage Accounts Production Advanced 2023 - FRS102_2023 760,000 760,000 760,000 xbrli:pure xbrli:shares iso4217:GBP 12173456 2023-05-01 2024-04-30 12173456 2024-04-30 12173456 2023-04-30 12173456 2022-05-01 2023-04-30 12173456 2023-04-30 12173456 2022-04-30 12173456 bus:OrdinaryShareClass1 2023-05-01 2024-04-30 12173456 bus:OrdinaryShareClass2 2023-05-01 2024-04-30 12173456 bus:OrdinaryShareClass3 2023-05-01 2024-04-30 12173456 bus:OrdinaryShareClass4 2023-05-01 2024-04-30 12173456 bus:Director1 2023-05-01 2024-04-30 12173456 bus:Director2 2023-05-01 2024-04-30 12173456 core:WithinOneYear 2024-04-30 12173456 core:WithinOneYear 2023-04-30 12173456 core:AfterOneYear 2023-04-30 12173456 core:ShareCapital 2024-04-30 12173456 core:ShareCapital 2023-04-30 12173456 core:RetainedEarningsAccumulatedLosses 2024-04-30 12173456 core:RetainedEarningsAccumulatedLosses 2023-04-30 12173456 core:CostValuation core:Non-currentFinancialInstruments 2024-04-30 12173456 core:Non-currentFinancialInstruments 2024-04-30 12173456 core:Non-currentFinancialInstruments 2023-04-30 12173456 bus:SmallEntities 2023-05-01 2024-04-30 12173456 bus:AuditExempt-NoAccountantsReport 2023-05-01 2024-04-30 12173456 bus:SmallCompaniesRegimeForAccounts 2023-05-01 2024-04-30 12173456 bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 12173456 bus:FullAccounts 2023-05-01 2024-04-30 12173456 bus:OrdinaryShareClass1 2024-04-30 12173456 bus:OrdinaryShareClass1 2023-04-30 12173456 bus:OrdinaryShareClass2 2024-04-30 12173456 bus:OrdinaryShareClass2 2023-04-30 12173456 bus:OrdinaryShareClass3 2024-04-30 12173456 bus:OrdinaryShareClass3 2023-04-30 12173456 bus:OrdinaryShareClass4 2024-04-30 12173456 bus:OrdinaryShareClass4 2023-04-30 12173456 bus:AllOrdinaryShares 2024-04-30 12173456 bus:AllOrdinaryShares 2023-04-30 12173456 1 2023-05-01 2024-04-30
COMPANY REGISTRATION NUMBER: 12173456
BSN Group Limited
Filleted Unaudited Financial Statements
30 April 2024
BSN Group Limited
Statement of Financial Position
30 April 2024
2024
2023
Note
£
£
Fixed assets
Investments
4
760,000
760,000
Creditors: amounts falling due within one year
5
106,500
46,000
---------
--------
Net current liabilities
106,500
46,000
---------
---------
Total assets less current liabilities
653,500
714,000
Creditors: amounts falling due after more than one year
6
148,000
---------
---------
Net assets
653,500
566,000
---------
---------
Capital and reserves
Called up share capital
7
10,000
10,000
Profit and loss account
643,500
556,000
---------
---------
Shareholders funds
653,500
566,000
---------
---------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 20 January 2025 , and are signed on behalf of the board by:
Mrs H E Justice
Mrs P D Miller-Hawkes
Director
Director
Company registration number: 12173456
BSN Group Limited
Notes to the Financial Statements
Year ended 30 April 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 3B Swallowfield Courtyard, Wolverhampton Road, Oldbury, West Midlands, B69 2JG.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Disclosure exemptions
The entity satisfies the criteria of being a small entity as defined in FRS102 and section 382 of the Companies Act 2006 and has taken advantage of the disclosure exemptions available under paragraph 1A.7 of FRS102.
Consolidation
The company has taken advantage of the option not to prepare consolidated financial statements contained in Section 398 of the Companies Act 2006 on the basis that the company and its subsidiary undertakings comprise a small group.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost.
4. Investments
Shares in group undertakings
£
Cost
At 1 May 2023 and 30 April 2024
760,000
---------
Impairment
At 1 May 2023 and 30 April 2024
---------
Carrying amount
At 30 April 2024
760,000
---------
At 30 April 2023
760,000
---------
5. Creditors: amounts falling due within one year
2024
2023
£
£
Other creditors
106,500
46,000
---------
--------
6. Creditors: amounts falling due after more than one year
2024
2023
£
£
Other creditors
148,000
----
---------
7. Called up share capital
Issued, called up and fully paid
2024
2023
No.
£
No.
£
Ordinary A shares of £ 1 each
4,999
4,999
4,999
4,999
Ordinary B shares of £ 1 each
4,999
4,999
4,999
4,999
Ordinary C shares of £ 1 each
1
1
1
1
Ordinary D shares of £ 1 each
1
1
1
1
--------
--------
--------
--------
10,000
10,000
10,000
10,000
--------
--------
--------
--------
The A Ordinary shares, the B Ordinary shares, the C Ordinary shares and the D Ordinary shares have equal voting rights and rank equally in a winding up.
8. Controlling party
The directors consider that no one individual controls the company.